Russell Investments »

Halozyme Therapeutics Inc Note 1.000 8/1 shares owned by Russell Investments

Quarter-by-quarter ownership of Halozyme Therapeutics Inc Note 1.000 8/1 shares owned by Russell Investments from 13F filings

Historical chart of Russell Investments investment in Halozyme Therapeutics Inc Note 1.000 8/1

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics Inc Note 1.000 8/1 held by Russell Investments consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics Inc Note 1.000 8/1 by Russell Investments

Quarter filed Position value Share count Share price at filing
2025-09-30 $327k 232k 1.41
2025-06-30 $375k 327k 1.15
2025-03-31 $420k 327k 1.28
2024-12-31 $464k 428k 1.08
2024-09-30 $510k 428k 1.19
2024-06-30 $478k 428k 1.12
2024-03-31 $418k 428k 0.98

More positions owned by Russell Investments

Nvidia Corp Common Stock (NVDA)
Microsoft Corp Common Stock (MSFT)
Apple Common Stock (AAPL)
Amazon Common Stock (AMZN)
Meta Platforms Common Stock (META)
Alphabet Common Stock (GOOGL)
Alphabet Common Stock (GOOG)
Broadcom Common Stock (AVGO)
Taiwan Semiconductor Manufacturing Common Stock (TSM)
Mastercard Incorporated Common Stock (MA)
Tesla Common Stock (TSLA)
Welltower Common Stock (WELL)
J P Morgan Chase And Common Stock (JPM)
Visa Common Stock (V)
Oracle Corp Common Stock (ORCL)

View all positions for Russell Investments

Top funds holding Halozyme Therapeutics Inc Note 1.000 8/1

Millennium Management
LMR Partners
Calamos Advisors
Camden Asset Management
Balyasny Asset Management
DLD Asset Management
Point72 Asset Management
Davidson Kempner Capital Management
Jpmorgan Chase & Co
Jain Global
Nuveen
Lazard Asset Management
State Street Corporation
Absolute Investment Advisers
Citadel Advisors

View all funds holding Halozyme Therapeutics Inc Note 1.000 8/1